Daiichi Sankyo has entered into an exclusive licence agreement worth up to $300m with Alteogen to develop a subcutaneous ...

FRONTERA GROUP FRONTERA GROUP is a cross-functional blend of behaviour and creative engagement experts. Our approach identifies the underlying drivers of decision making, to uncover how choices are ...

MCG Medical Consulting Group The MCG Medical Consulting Group is a specialist on the healthcare market, owner-managed communications agency based in Dusseldorf. We develop and implement for our ...

GSK has announced that it will be expanding its immunology pipeline by acquiring a clinical-stage T cell-engager from ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission (EC) to treat eosinophilic ...

Chiesi Group and Oak Hill Bio have announced that the first European patient has been enrolled in a phase 2b study evaluating ...

The companies will use Ascendis’ TransCon technology to develop therapies for metabolic and cardiovascular diseases ...

Johnson & Johnson (J&J) has announced that its pan-FGFR tyrosine kinase inhibitor Balversa (erdafitinib) has been granted ...

PharmaNet/i3 PharmaNet/i3, a leader in drug development services, has a global infrastructure, therapeutic expertise, and commitment to quality that is unmatched in the industry. For pharmaceutical, ...

Central Homecare Since 1994 Central Homecare has been building an enviable reputation as a high quality provider of high-tech’ home care in the UK. This is a FREE LISTING on PMHUB Below are full ...

Bioconvey Health Communications Bioconvey is a medical communications agency headquartered in Poland. Our team of dedicated medical writers works passionately with key actors in the healthcare ...

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market. Large CROs prioritise studies from the big pharma companies, for ...